Those holding Aurora Cannabis Inc. (TSE:ACB) shares would be relieved that the share price has rebounded 29% in the last thirty days, but it needs to keep going to repair the recent damage it has caused to investor portfolios. Not all shareholders will be feeling jubilant, since the share price is still down a very disappointing 14% in the last twelve months.
Since its price has surged higher, when almost half of the companies in Canada’s Pharmaceuticals industry have price-to-sales ratios (or “P/S”) below 0.7x, you may consider Aurora Cannabis as a stock probably not worth researching with its 1.3x P/S ratio. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s as high as it is.
View our latest analysis for Aurora Cannabis
